Clinical compliance risk is enterprise risk.

Clinical compliance risk is enterprise risk — CPT, The Compliance CRO
Read this page as text

For Sponsors • Boards • Investors • Acquirers & Licensing Partners

Clinical compliance risk is enterprise risk.

ClinPro Trials independently examines clinical trial execution and compliance evidence for those responsible for trials and those making decisions about clinical-stage assets.

The clinical trial ecosystem

Sponsor · CRO · Sites · Vendors · Data · Safety · Oversight. Multiple organizations. Multiple systems. One accountable sponsor.

What CPT independently examines

Execution drift · Data integrity gaps · Protocol deviations · Safety risks · CRO and vendor oversight gaps · Monitoring gaps · Documentation gaps · Inspection exposure

We don’t run the trial.

We independently examine execution and compliance evidence. We report findings and materiality without assuming operational responsibility. Your CRO executes. Your management team manages. CPT independently examines. Independent. Evidence-based. Confidential.

Two distinct service pathways

  • Clinical Execution Assessment — for sponsors and boards: Independent visibility into clinical execution, oversight and compliance exposure.
  • Clinical Execution Diligence — for investors, acquirers and licensing partners: Independent findings relevant to capital, transaction and partnership decisions.

Request an independent assessment

Outcomes that matter: Executive visibility — See what matters most. · Risk prioritization — Focus on material risk. · Governance visibility — See oversight clearly. · Regulatory risk visibility — See exposure early. · Informed decision-making — Decide with confidence.

Confidential. Independent. Evidence-based.